Back to Search Start Over

Factors associated with health-related quality of life in heart failure in 23 000 patients from 40 countries: results of the G-CHF research programme

Authors :
Isabelle, Johansson
Kumar, Balasubramanian
Shrikant, Bangdiwala
Lisa, Mielniczuk
Camilla, Hage
Sanjib Kumar, Sharma
Kelley, Branch
Jun, Zhu
Kristian, Kragholm
Karen, Sliwa
Francois, Alla
Gerald, Yonga
Ambuj, Roy
Andres, Orlandini
Alex, Grinvalds
Tara, McCready
Nana, Pogosova
Stefan, Störk
John J V, McMurray
David, Conen
Salim, Yusuf
Bordeaux population health (BPH)
Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Bayer
Source :
Johansson, I, Balasubramanian, K, Bangdiwala, S, Mielniczuk, L, Hage, C, Sharma, S K, Branch, K, Zhu, J, Kragholm, K, Sliwa, K, Alla, F, Yonga, G, Roy, A, Orlandini, A, Grinvalds, A, McCready, T, Pogosova, N, Störk, S, McMurray, J J V, Conen, D, Yusuf, S & The GCHF investigators 2022, ' Factors associated with health-related quality of life in heart failure in 23,000 patients from 40 countries : results of the G-CHF research programme ', European Journal of Heart Failure, vol. 24, no. 9, pp. 1478-1490 . https://doi.org/10.1002/ejhf.2535, European Journal of Heart Failure, European Journal of Heart Failure, Oxford University Press (OUP), 2022, ⟨10.1002/ejhf.2535⟩
Publication Year :
2022

Abstract

Aims: To examine clinical and social correlates of health-related quality of life (HRQL) in patients with heart failure (HF) from high- (HIC), upper middle- (UMIC), lower middle- (LMIC) and low-income (LIC) countries. Methods and results: Between 2017 and 2020, 23 292 patients with HF (32% inpatients, 61% men) from 40 countries were enrolled in the Global Congestive Heart Failure study. HRQL was recorded at baseline using the Kansas City Cardiomyopathy Questionnaire (KCCQ)-12. In a cross-sectional analysis, we compared age- and sex-adjusted mean KCCQ-12 summary scores (SS: 0–100, higher = better) between patients from different country income levels. We used multivariable linear regression examining correlations (estimated coefficients) of KCCQ-12-SS with sociodemographic, comorbidity, treatment and symptom covariates. The adjusted model (37 covariates) was informed by univariable findings, clinical importance and backward selection. Mean age was 63 years and 40% of patients were in New York Heart Association (NYHA) class III–IV. Average HRQL was 55 SD 27. It was 62.5 (95% confidence interval [CI] 62.0–63.1) in HIC, 56.8 (56.1–57.4) in UMIC, 48.6 (48.0–49.3) in LMIC, and 38.5 (37.3–39.7) in LICs (p < 0.0001). Strong correlates (estimated coefficient [95% CI]) of KCCQ-12-SS were NYHA class III versus class I/II (−12.1 [−12.8 to −11.4] and class IV versus class I/II (−16.5 [−17.7 to −15.3]), effort dyspnoea (−9.5 [−10.2 to −8.8]) and living in LIC versus HIC (−5.8 [−7.1 to −4.4]). Symptoms explained most of the KCCQ-12-SS variability (partial R 2 = 0.32 of total adjusted R 2 = 0.51), followed by sociodemographic factors (R 2 = 0.12). Results were consistent in populations across income levels. Conclusion: The most important correlates of HRQL in HF patients relate to HF symptom severity, irrespective of country income level.

Details

ISSN :
18790844 and 13889842
Volume :
24
Issue :
9
Database :
OpenAIRE
Journal :
European journal of heart failureReferences
Accession number :
edsair.doi.dedup.....9ebd7251f4f2f8a09083a0a1eb5fa991